Positive Data for Co-administered Flu Vaccine and COVID-19 Vaccine
Positive results from the first co-administration study of a SARS-CoV-2 vaccine candidate and an approved influenza vaccine have been published in The Lancet Respiratory Medicine.
Category: Intl’ Pharmaceuticals
Intl' Pharmaceuticals
Latest
Intl' Pharmaceuticals
Latest
Moderna, Pfizer Vaccines Proving 90% Effective
The CDC reports risk of COVID-19 infection following the second dose of Moderna or Pfizer's vaccine was reduced by 90% two or more weeks after vaccination.
Intl' Pharmaceuticals
Latest
Novartis to Aid Pfizer COVID-19 Vaccine Production
Pharmaceutical company Novartis will assist Pfizer and BioNTech in the production of their COVID-19 vaccine.
Canada OKs Pfizer COVID-19 Vaccine
Canada became the third nation to authorize the COVID-19 vaccine produced by Pfizer and BioNTech after the UK and Bahrain did so last week.
Read More
UK Authorizes Pfizer COVID-19 Vaccine
UK regulators granted emergency authorization to Pfizer’s and BioNTech’s COVID-19 vaccine, which was 95% effective in preventing infections according to Phase 3 data.
Read More
Aerogen Collaborating on COVID-19 Therapeutics
Aerogen has released details of a broad collaborative effort to support pharmaceutical companies...
Read More
Positive Data for Merck’s Pneumococcal Conjugate Vaccine Candidate
Two Phase 3 studies of Merck’s investigational 15-valent pneumococcal conjugate vaccine met their primary immunogenicity objectives.
Read More
AstraZeneca Halts Phase 3 Study of COVID-19 Vaccine after Illness
“A potentially unexplained illness” in a recipient of AstraZeneca’s COVID-19 vaccine candidate AZD1222 has halted the company’s phase 3 clinical trial, the AP reports.
Read More
AstraZeneca’s COVID-19 Vaccine Candidate Begins Phase 3 Trial
The multi-site, Phase 3 clinical trial will enroll 30,000 adults in order to evaluate AstraZeneca’s investigational COVID-19 vaccine known as AZD1222.
Read More
FDA Approves Generic Albuterol Sulfate
The FDA approved an Abbreviated New Drug Application for Lupin Ltd’s albuterol sulfate inhalation aerosol 90 mcg, a generic for Teva’s ProAir HFA.
Read More
Cystic Fibrosis Drug Kaftrio Will Become Available on NHS
The drug, Kaftrio, produced by Vertex Pharmaceuticals, will be available through the NHS to many who have cystic fibrosis.
Read More
Russia COVID-19 Vaccine Reportedly Tested on Just 76 Humans
The COVID-19 vaccine, known as ‘Sputnik V’ and developed by the Gamaleya Research Institute in Moscow, has reportedly been tested in just 76 humans.
Read More
COVID-19 Vaccine Candidate Protected Upper, Lower Airways in Primate Study
Two doses of Moderna’s experimental COVID-19 vaccine induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2.
Read More
Unclear Results for Gilead’s Remdesivir for Severe Covid-19
The first clinical results for remdesivir’s effectiveness on severe COVID-19 demonstrated clinical improvements but remain unclear because no control group was included in the study.
Read More
Fluzone High-Dose Quadrivalent Approved for Adults 65+
The FDA has approved the Fluzone High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older. The vaccine will be available for fall 2020.
Read More